At the Greater Philadelphia Business Coalition on Health 2023 Wellness Summit, Seun Ross, PhD, explains the business case for achieving health equity.
In her presentation, “Driving Health Equity in Population Health Programs,” at the Greater Philadelphia Business Coalition on Health (GPBCH) 2023 Wellness Summit, Seun Ross, PhD, executive director of health equity for Independence Blue Cross, addressed the multifaceted aspects of health equity and why it is imperative to strive for it.
Transcription
What were the key takeaways from your presentation "Driving Health Equity in Population Health Programs"?
Health Equity is important. It is a business imperative and also a social mission, it is not either or, it is an “and.” There is a business case for health equity. Achieving health equity is important so that we can sustain the health care system. Without trying to achieve health equity, the health care system would undergo serious burdens that it may not be able to sustain.
Can you share the different perspectives of what health equity means to different communities?
When people often think of health equity, they think of health equity as it relates between the races, so closing disparities between white and Black, or Latino and White, or Asian and Hispanic. But I think the health equity is much broader than that. When you think of health equity, everyone receives care and so we need to think about achieving health equity between genders, between if you are abled or differently abled, and that encompasses all of the physical or chronic conditions that people deal with every day.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
AUA Posters Highlight Racial Gaps in PSA Screening, Prostate Cancer Risk
May 4th 2024Speakers discussed the disparities in prostate-specific antigen (PSA) screening rates among different racial groups and explored the potential of free PSA percentage as a predictive marker for future prostate cancer risk.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bimekizumab Shows Promising 52-Week Safety and Efficacy in Psoriatic Arthritis
May 3rd 2024Promising results presented at the Academy of Managed Care Pharmacy 2024 annual meeting support the safety and efficacy of bimekizumab treatment in patients with active psoriatic arthritis who had previously shown inadequate response or intolerance to tumor necrosis factor inhibitors.
Read More